Biostage, Inc., a biotechnology company, engages in developing bioengineered organ implants based on its Cellframe technology. The company s Cellframe technology combines the synthetic scaffold with tissue engineering and cell biology to create method of addressing organ damage. Its Cellframe technology stimulates the body s signaling pathways and natural healing process to regenerate and restore organ function. The company is developing organ implants as a platform of being used in the esophagus, trachea, and bronchi. Its implants are being advanced and tested in a preclinical collaborative study with Mayo Clinic. The company was formerly known as Harvard Apparatus Regenerative Technology, Inc. and changed its name to Biostage, Inc. in March . Biostage, Inc. was founded in and is headquartered in Holliston, Massachusetts.
Quote | Biostage (OTC:BSTG)
|Last Trade Date Time:||12/31/1969 07:00:00 pm|
News | Biostage (OTC:BSTG)
HOLLISTON, Mass., May 31, 2023 (GLOBE NEWSWIRE) -- Biostage, Inc. (OTCQB: BSTG) (“Biostage” or the “Company”), a clinical-stage biotechnology company developing the technology to regenerate organs inside the body to treat severe diseases, including cancer, trau...
HOLLISTON, Mass., April 10, 2023 (GLOBE NEWSWIRE) -- Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the "Company"), a cell-therapy biotechnology company with successful first-in-human experience in treating esophageal cancer and FDA approval to commence a clinical trial of the Biostage Esophageal Im...
Message Board Posts | Biostage (OTC:BSTG)
|NEWS !!!||Fedel||investorshub||01/12/2022 5:02:31 PM|
|Has anything changed in the company at the moment?||Androped12||investorshub||09/07/2020 7:11:24 PM|
|Interesting chart.||jjr04001||investorshub||07/18/2020 4:34:34 PM|
|Whole management team a bunch of scumbags. Mcgorry||AKthisistheone||investorshub||01/30/2019 1:48:29 PM|
|The mgmt is a bunch of liars. Their||spoiler||investorshub||12/18/2018 12:51:31 PM|
Biostage Company Name:
BSTG Stock Symbol:
News, Short Squeeze, Breakout and More Instantly...